Polyrizon Ltd. (PLRZ)

NASDAQ: PLRZ · Real-Time Price · USD

0.31

-0.03 (-8.82%)

At close: Apr 28, 2025, 3:59 PM

0.33

5.55%

After-hours: Apr 28, 2025, 05:20 PM EDT

-8.82% (1D)

Bid	0.3
Market Cap	1.45M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
EPS (ttm)	-0.5
PE Ratio (ttm)	-0.63
Forward PE	n/a
Analyst	n/a

Ask	0.34
Volume	313,147
Avg. Volume (20D)	377,670
Open	0.32
Previous Close	0.34
Day's Range	0.31 - 0.33
52-Week Range	0.28 - 4.80
Beta	-3.74

About PLRZ

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel....

[Read more]

Industry Biotechnology

Sector Healthcare

IPO Date Oct 29, 2024

Employees 2

Stock Exchange NASDAQ

Ticker Symbol PLRZ

Website https://www.polyrizon-biotech.com

Full Company Profile